OcuLenz
Millions of people living with central vision loss lack effective solutions that restore functional sight. Existing tools fail to address the scotomas (blindspots), leaving these people unable to read, recognize faces, or navigate independently. OcuLenz introduces a new category: software enabled vision correction.
Market Opportunity
200M people globally affected by AMD
85% of low vision patients report dissatisfaction with existing aids
<15% adoption rate of traditional assistive devices
OcuLenz has raised $20M+ in funding to support development and commercialization. This funding supports clinical validation, product development, and go-to-market expansion.
From Tech Device to Independent Lifestyle
Functional independence: read, recognize, navigate
Personalized vision: adaptive to each user
Beyond traditional solutions: solves blind spots
Shifted positioning away from hardware and toward functional outcomes. Built messaging framework translating complex XR technology into human impact.
Clinic Led GTM with Caregiver Driven Demand
Retina specialists & low vision clinics: credibility + validation
Direct-to-consumer: education driven acquisition
Partnerships: vision foundations, aging organizations
Built a dual-channel GTM strategy prioritizing clinical trust while activating caregiver-led demand generation.
Clinic validation → Patient demo → Caregiver conversion → Guided onboarding
→
Clinic validation → Patient demo → Caregiver conversion → Guided onboarding →
Adoption & User Experience Strategy
Structured onboarding program: clinic + at-home support
Simplified UX messaging and training content
Caregiver-inclusive product experience
Identified onboarding and usability as primary barriers to adoption. Partnered cross-functionally to design a guided experience for elderly users and caregivers.
Market Value, Backed by Investor Confidence
OcuLenz is positioned within a large and underserved market, where unmet need and aging demographics create strong long-term demand. The product’s category-defining approach aligns with growing investor interest in digital health, assistive technology, and XR-enabled care.
Framed the product within a high-growth market narrative, connecting user need to business opportunity and supporting a story that resonates with both customers and investors.